Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Aurora Cannabis Inc.TSX: ACB.TO

Income Tax Expense · Q4 FY2026 · quarter ended Mar 2026

Income tax expense turns negative

Q4 FY2026 income tax expense was -CA$4.26M, compared with CA$1.99M a year earlier. Trailing-twelve-month income tax expense was -CA$3.25M.

Context

  • Income tax expense amounted to 0.7% of revenue in FY2026, down 0.7 pp from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly income tax expense holds near -CA$4.26M or moves back toward the trailing-twelve-month quarterly average of -CA$813.5K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$4.26M-2695.1% QoQ
Last fiscal yearMar 2026
CA$2.1M-54.6% YoY
LTMMar 2026
-CA$3.25M-170.4% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-313.5%——
1 year-54.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

CAD · from the income statement

Latest · FY2026
2.1M CAD
Year-over-year change
-54.6%

Income Tax Expense vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -170.4% is the 6th highest of 7, against a peer median of -72.8%.
  • Income tax expense amounts to 1.0% of revenue for ACB.TO, versus a peer median of 0.8%.
ACB.TO Competitors
Income Tax Expense for ACB.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TSND.TOTerrAscend Corp.LTM Mar 2026$29.02M USD+30.6%—11.1%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$23K CAD-99.7%—0.0%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$0 USD-100.0%-10.3%0.0%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$0 CAD——0.0%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026-CA$1.21M CAD+85.1%—0.8%
ACB.TOAurora Cannabis Inc.LTM Mar 2026-CA$3.25M CAD-170.4%—1.0%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026-$10.76M USD-45.9%—21.1%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$13.66M CAD-17878.9%—5.0%
Peer median (excluding ACB.TO) —-72.8%-10.3%0.8%

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.